Paladin Labs Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Paladin Labs Inc..The latest application filed is for "starch-based microparticles for the release of agents disposed therein".

Company Profile

3.25.26

Paladin Labs Inc. - Montreal N/A CA
Paladin Labs Inc. - Montreal Quebec
Paladin Labs, Inc. - CA CA
PALADIN LABS INC. -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Solid formulations of liquid biologically active agents Grant 10,561,735 - Ravenelle , et al. Feb	2020-02-18
Starch-based Microparticles For The Release Of Agents Disposed Therein App 20180193466 - Rahmouni; Miloud ; et al.	2018-07-12
Misuse Preventative, Controlled Release Formulation App 20180185292 - Rahmouni; Miloud ; et al.	2018-07-05
Misuse Preventative, Controlled Release Formulation App 20180185289 - Rahmouni; Miloud ; et al.	2018-07-05
Solid Formulations Of Liquid Biologically Active Agents App 20180140706 - Ravenelle; Francois ; et al.	2018-05-24
Oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides and uses thereof Grant 9,719,091 - Damha , et al. August 1, 2	2017-08-01
Misuse Preventative, Controlled Release Formulation App 20160367483 - Rahmouni; Miloud ; et al.	2016-12-22
Misuse Preventative, Controlled Release Formulation App 20160310432 - Rahmouni; Miloud ; et al.	2016-10-27
Solid Formulations Of Liquid Biologically Active Agents App 20160193341 - Ravenelle; Francois ; et al.	2016-07-07
Oligonucleotide Duplexes Comprising Dna-like And Rna-like Nucleotides And Uses Thereof App 20160145613 - Damha; Masad J. ; et al.	2016-05-26
Misuse Preventative, Controlled Release Formulation App 20150272890 - Rahmouni; Miloud ; et al.	2015-10-01
Misuse Preventative, Controlled Release Formulation App 20150272888 - Rahmouni; Miloud ; et al.	2015-10-01
Oligonucleotide duplexes comprising DNA-like and RNA-like nucleotides and uses thereof Grant 9,090,649 - Damha , et al. July 28, 2	2015-07-28
Misuse preventative, controlled release formulation Grant 8,927,014 - Rahmouni , et al. January 6, 2	2015-01-06
Misuse preventative, controlled release formulation Grant 8,927,013 - Rahmouni , et al. January 6, 2	2015-01-06
Misuse preventative, controlled release formulation Grant 08920833 -	2014-12-30
Misuse preventative, controlled release formulation Grant 8,920,833 - Rahmouni , et al. December 30, 2	2014-12-30
Misuse preventative, controlled release formulation Grant 8,920,834 - Rahmouni , et al. December 30, 2	2014-12-30
Misuse preventative, controlled release formulation Grant 08920834 -	2014-12-30
Bilayer composition for the sustained release of acetaminophen and tramadol Grant 8,895,066 - Bichara , et al. November 25, 2	2014-11-25
Solid Formulations Of Liquid Biologically Active Agents App 20140323587 - Ravenelle; Francois ; et al.	2014-10-30
Misuse Preventative, Controlled Release Formulation App 20140294955 - Rahmouni; Miloud ; et al.	2014-10-02
Misuse Preventative, Controlled Release Formulation App 20140294954 - Rahmouni; Miloud ; et al.	2014-10-02
Misuse Preventative, Controlled Release Formulation App 20140248346 - Rahmouni; Miloud ; et al.	2014-09-04
Starch-based Microparticles For The Release Of Agents Disposed Therein App 20140206704 - Rahmouni; Miloud ; et al.	2014-07-24
Misuse Preventative, Controlled Release Formulation App 20140193494 - Rahmouni; Miloud ; et al.	2014-07-10
Misuse preventative, controlled release formulation Grant 8,691,270 - Rahmouni , et al. April 8, 2	2014-04-08
Misuse preventative, controlled release formulation Grant 8,685,447 - Rahmouni , et al. April 1, 2	2014-04-01
Misuse Preventative, Controlled Release Formulation App 20140004191 - Rahmouni; Miloud ; et al.	2014-01-02
Misuse Preventative, Controlled Release Formulation App 20130344142 - Rahmouni; Miloud ; et al.	2013-12-26
Controlled-release compositions Grant 8,487,002 - Lenaerts , et al. July 16, 2	2013-07-16
Misuse preventative, controlled release formulation Grant 8,486,448 - Rahmouni , et al. July 16, 2	2013-07-16
Misuse preventative, controlled release formulation Grant 8,486,449 - Rahmouni , et al. July 16, 2	2013-07-16
Narcotic drug formulations with decreased abuse potential Grant 8,460,640 - Vinson , et al. June 11, 2	2013-06-11
Chimeric Antigens For Eliciting An Immune Response App 20120070435 - George; Rajan ; et al.	2012-03-22
Chimeric antigens for eliciting an immune response Grant 8,029,803 - George , et al. October 4, 2	2011-10-04
Narcotic Drug Formulations with Decreased Abuse Potential App 20110237615 - Vinson; Robert ; et al.	2011-09-29
Chimeric antigens for eliciting an immune response Grant 8,025,873 - George , et al. September 27, 2	2011-09-27
Chimeric antigens for breaking host tolerance to foreign antigens Grant 8,007,805 - George , et al. August 30, 2	2011-08-30

Company Registrations

NCAGE Code	L9857	PALADIN LABS INC
CAGE Code	L9857	PALADIN LABS INC
SEC	0001603200	PALADIN LABS INC

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.